|
Giving the B vitamin thiamine
(Vitamin B1) to patients with chronic hepatitis B infection
improves signs of the disease,
a small preliminary study has found. This could point the
way to a cheap and nontoxic way of treating the infection.
Hepatitis B virus (HBV) is spread through
contact with the blood or body fluids of an infected person.
HBV infects the liver, and in severe cases can lead to cirrhosis,
liver cancer and liver failure. HBV can be treated with antiviral
drugs and interferon, but there
is no cure.
A researcher decided to test thiamine
for HBV after a very bright and aware patient observed that
his aminotransferase levels
rose and fell depending on whether he was taking the vitamin.
High levels of aminotransferase enzymes
indicate more active infection of the liver.
Investigators conducted a trial in this
patient and two others with HBV infection to investigate the
relationship. All had either failed treatment with interferon
or could not tolerate the drug.
While patients were on thiamine treatment,
their aminotransferase
levels fell from abnormally high to normal levels;
these levels increased when thiamine was subsequently withdrawn.
And in subsequent liver biopsies after thiamine treatment,
HBV DNA was undetectable.
This is the first study to investigate
thiamine for treating hepatitis B infection. There are several
potential ways that the vitamin might fight the infection.
For example, thiamine binds to iron and
thus reduces the iron load in the liver. Past studies have
linked high iron levels in the liver to more severe HBV infection,
as well as a worse response to interferon.
The American
Journal of Gastroenterology March 2001; 96: 864-868
|